novo nordisk patent semaglutide A major shift is coming to India's drug market that could change how millions access weight-loss medicine. In March, Nordisk's India for semaglutide, the key ingredient in Ozempic, will expire Semaglutide patent expiry in India
Pay in 4 interest-free payments of $7.48 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21







![Victoza Lawsuit [2026 Update]](https://www.torhoermanlaw.com/wp-content/uploads/2021/07/Victoza-Lawsuit-TorHoerman-Law_-Speak-to-an-Experienced-Victoza-Lawyer-Torhoerman-Law.jpg)







![west virginia glp-1 pancreatitis law firm Victoza Lawsuit [2026 Update] Ozempic](https://libn.com/files/2026/06/focus626.jpg)





